SCHEMBL366672

SCHEMBL366672

Fc1ccc(Oc2cccc3cccnc23)cc1F

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.53
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
RAB9A P51151 2/20 0.49
NPC1 O15118 1/20 0.49
LMNA P02545 4/20 0.47
MAPT P10636 5/20 0.47
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C19 P33261 1/20 0.46
GLO1 Q04760 1/20 0.45
ALDH1A1 P00352 3/20 0.44
GAA P10253 2/20 0.44
HTT P42858 2/20 0.44
MAPK1 P28482 1/20 0.44
POLB P06746 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
HTR2A P28223 1/20 0.43
SLC6A4 P31645 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6026021 0.87 MEN1 (0.49) KDM4EMEN1KMT2ARAB9ANPC1
SCHEMBL7208902 0.83 KDM4E (0.54) KDM4EMEN1KMT2ARAB9ANPC1
SCHEMBL7212405 0.80 KDM4E (0.54) KDM4EMEN1KMT2ARAB9ANPC1
SCHEMBL9338879 0.78 HTR2A (0.49) KMT2ALMNACYP3A4CYP2C19HTR2A
SCHEMBL9338875 0.78 HTR2A (0.46) KDM4EKMT2ALMNACYP2C19HTR2A
SCHEMBL7212478 0.78 KDM4E (0.55) KDM4EMEN1KMT2ARAB9ANPC1
SCHEMBL4386263 0.78 KDM4E (0.72) KDM4EMEN1KMT2ARAB9ANPC1
SCHEMBL546185 0.77 RAB9A (0.68) KDM4EMEN1KMT2ARAB9ANPC1
SCHEMBL9446981 0.77 KDM4E (0.54) KDM4EMEN1KMT2ARAB9ANPC1
SCHEMBL6027467 0.77 NPC1 (0.74) KDM4EMEN1KMT2ARAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8097644-B2 Indole compounds having sphingosine-1-phosphate (S1P) receptor antagonist ALLERGAN, INC. (US) 2012-01-17 US disclosed
US-20070232682-A1 Indole Compounds having sphingosine-1-phosphate (S1P) receptor antagonist ALLERGAN, INC. (US) 2007-10-04 US disclosed
WO-2007112322-A2 INDOLE COMPOUNDS HAVING SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTOR AGONIST AND/OR ANTAGONIST BIOLOGICAL ACTIVITY ALLERGAN, INC. (US) 2007-10-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232682-A1 Indole Compounds having sphingosine-1-phosphate (S1P) receptor antagonist S1PR1, S1PR2, S1PR3 KDM4E 2802/4885MEN1 3212/4885KMT2A 4465/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.